Advancing Clinical Capabilities to Empower Better Outcomes

Discover how our philosophy of Advancing Clinical Capabilities is helping us deliver greater insights in areas like women’s health, cardiovascular disease, infectious disease, and beyond.
Advancing Clinical Capabilities to Empower Better Outcomes

A woman seeking critical answers to help plan for the family she desires.

A grandfather who doesn’t plan to let a family history of heart disease slow him down.

A young man awaiting test results that could set a life-altering care plan in motion.

Even when you’re not in the exam room with them, we know patients are always on your mind. Every diagnostic test holds the potential to reveal greater insights into their health today so you can guide them toward a healthier tomorrow. That’s why we focus on innovations designed to advance your clinical capabilities—from the exam room to the lab and beyond.

What Does it Mean to Advance Clinical Capabilities?

The demands placed on clinical and laboratory teams today aren’t just growing. They’re changing. More complex diseases, combined with a broader range of conditions and patient populations, make it important to continuously advance your research and clinical capabilities to help best meet patients’ needs.

Our philosophy of Advancing Clinical Capabilities is designed to help you prioritize both efficiency and clinical outcomes. We do it through:

  • Clinical confidence: Precise, accurate test results that labs, clinicians, and patients can trust
  • Improved efficiency: Fully automated testing that delivers insightful data with a rapid turnaround time
  • Collaborative intelligence: Meaningful partnerships with research and healthcare professionals that power breakthroughs with real-world clinical impacts

How Are We Advancing Clinical Capabilities?

We focus our innovation on solutions that deliver diagnostics that are accurate, sensitive, timely, accessible, and less invasive. These innovations span many areas of healthcare, including:

Women’s Health
Every woman deserves clarity in her reproductive health. Our comprehensive testing menu delivers proven biomarkers with exceptional sensitivity and broad measuring ranges1—equipping labs and clinicians with the insights they need to guide life-changing decisions and improve outcomes. For example:

  • Our Access AMH (Anti-Müllerian Hormone) delivers fertility testing results that are fast, consistent, and dependable—reducing laboratory costs by 16% compared with typical manual tests for assessing ovarian reserve2
  • Our Access Sensitive Estradiol assay strengthens your confidence in low-end results with state-of-the-art sensitivity. At the same time, it creates efficiencies and helps reduce costly dilutions with the broadest dynamic range that surpasses IVF hyper-response guidelines1

Cardiovascular Disease
Every minute matters when diagnosing heart disease, so you can’t afford to choose between speed and accuracy. Our comprehensive cardiac menu is designed to provide diagnostic support for patients at risk of, or experiencing, cardiovascular disease—delivering the trustworthy results you need to support time-sensitive care.

  • Both Access NT-proBNP and Access BNP assays deliver results in 11-16 minutes3,4 respectively, aiding in faster diagnosis and treatment of cardiac patients
  • High-sensitivity troponin tests support more rapid decision-making, which can help detect, triage, and manage at-risk patients sooner5 and send acute myocardial infarction (AMI) low-risk patients home faster6

Infectious Disease
The global fight against infectious disease needs all of us—together. With diagnostics for labs of all sizes, our infectious disease menu is designed to elevate your efficiency and confidence with high sensitivity and specificity.

  • Our Access HIV Ag/Ab combo assay has demonstrated 100% clinical sensitivity for clinical samples and viral lysates
  • Our validated HBsAg High Positive algorithm for Hepatitis B and C testing eliminates the need for repeat and confirmatory testing for samples ≥ 100.00 S/CO—with 96.9% of initially reactive samples able to be directly reported as positive

Advancing Clinical Capabilities and Powering the Moments that Matter

From patient rooms to the laboratory, diagnostics power the moments that matter across your organization. Backed by our philosophy of Advancing Clinical Capabilities, our instruments and assays are delivering more intelligence from every sample—so you can provide the right care and clinical oversight for the patients each sample represents.

Learn more about how we are advancing clinical capabilities, then talk to your Beckman Coulter representative about what it could mean for your organization.

References:

1. Based on Access Sensitive Estradiol assay specifications

2. Data available upon request

3. Beckman Coulter, Access NT-proBNP Data Sheet, C68287.B, Brea, CA 2024.

4. Beckman Coulter, Access BNP Instructions for Use, C79614, Brea, CA 2022.

5. Borke, J. Natriuretic Peptides in Congestive Heart Failure. March 9, 2021. Medscape. https://emedicine.medscape.com/article/761722-overview [Accessed: March 9, 2023]

6. Thygesen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012; 33: 2252-7. Korley FK, Jaffe AS. Preparing the United States for high-sensitivity cardiac troponin assays. J Am Coll Cardiol, 2013; 61:1753-8.

Editorial Team
Editorial Team
The Beckman Coulter editorial team brings you timely news and resources focused on elevating clinical laboratory performance and advancing patient care.

Related Articles

Advancing Clinical Capabilities to Empower Better Outcomes

Advancing Clinical Capabilities to Empower Better Outcomes

Discover how our philosophy of Advancing Clinical Capabilities is helping us deliver greater insights in areas like women’s health, cardiovascular disease, infectious disease, and beyond.
The Global Burden of Cardiovascular Disease in Women

The Global Burden of Cardiovascular Disease in Women

Based on "Women's Hearts: Biomarkers for Precision-based Care," a webinar with Dr. Emily Lau, MD, MPH. Dr. Lau is a cardiologist and public health expert specializing in cardiovascular disease prevention, heart failure, and women’s cardiac health. Her research focuses on risk prediction, sex-based differences in cardiovascular disease, and strategies to improve outcomes through evidence-based care.
Preparing Your Lab for the Fifth Industrial Revolution

Preparing Your Lab for the Fifth Industrial Revolution

Our own Timea Zsiray shares her insights into the rise of intelligent automation as labs move from the fourth industrial revolution into the fifth—and how our philosophy of Advantaged Workflows can help.